The @HyvonenGroup, @SpringGroupChem, Apollo Therapeutics and Sandexis have published a paper in Medicinal Chemistry describing the discovery of APL-5125. This highly selective and potent small molecule CK2a is now in a US Phase 1/2 clinical trial: https://t.co/uwnTVmBwTg
We are excited to share our new work on one carbon alkene homologation. We can iteratively homologate terminal and internal alkenes in simple and complex molecules using this method. Great work by Marcus that opens up lots of exciting opportunities for us. https://t.co/dvTgvTQxNl
#RachelBrazil examines progress by researchers to create a new generation of antibody drug conjugates to improve efficacy and minimise off-target adverse effects of these cancer therapies
#Enhertu#enfortumabvedotin#antibodydrugconjugate
https://t.co/WxXLRD6iCE
Happy New Year to all of our followers!🎇
Join us for our next webinar on Protein and Peptide Science on 7th February 1pm UK time.
Hear from Dr Sona Krajcovicova (University of Cambridge) & Dr Anna Peacock (University of Birmingham).
Register here https://t.co/sD1WFCoq1h
Very sad news of the passing of @sirfrasersays, a giant of chemistry for four decades. He pioneered (with J-P Sauvage) the chemistry of the mechanical bond (catenanes & rotaxanes) & recognised that their well defined motions could be useful for molecular machinery... 1/3
#SpringleMingle’s in Action: Congratulations to Saan Voss (@peptidestudio) for bringing home the 1st Luis Moroder award for the best conference presentation at the 18th peptide workshop in Naples!
It's also time that we welcome new PhD students Aryaman, Georgie, Sophie and Josh to the group! We've loved having you thus far and can't wait to see the amazing science you get up to over the next 3/4 years.
The @Gaunt_Group are looking for two enthusiastic and talented researchers to join our dynamic team in Cambridge, as postdocs. If you are interested in developing cutting edge synthetic chemistry across a wide range of areas relating to catalysis, apply at https://t.co/VWHY4Nyk0G
PhD studentship available in the group with @AstraZeneca in iron catalysis! Another inorganic catalysis PhD is also available !🧪🧪 @ChemCambridge
https://t.co/hsKccZzJdi
Come and join our team. We have an exciting Synthetic Chemistry PhD opportunity in the @Gaunt_Group (starting Oct 2025) in collaboration with AstraZeneca. It will focus development of new catalytic activation modes for the synthesis of novel scaffolds.
https://t.co/VwCnX6Vlbq
Very excited to see this work published! A huge thank you to our colleagues and collaborators, without whom this would not have been possible!
@NicolaAshman6, @JCarrollLab, The Welch Lab and @SpringGroupChem